https://www.selleckchem.com/products/ABT-263.html
How patients with atrial fibrillation (AF) and their clinicians consider cost in forming care plans remains unknown. To identify factors that inform conversations regarding costs of anticoagulants for treatment of AF between patients and clinicians and outcomes associated with these conversations. This cohort study of recorded encounters and participant surveys at 5 US medical centers (including academic, community, and safety-net centers) from the SDM4AFib randomized trial compared standard AF care with and without use of a shared deci
Like
Comment
Share
